Alx Oncology Holdings Inc

Research Alx Oncology Holdings Inc (ALXO) on Bullrun: market cap USD 296.04M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerALXO
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 296.04M
• Financial periodFY2025
• Net income-USD 101.70M
• Free cash flow-USD 84.35M

Valuation Snapshot

latest market cap is USD 296.04M.

About Alx Oncology Holdings Inc

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company's lead product candidate is Evorpacept, a CD47 blocking therapeutic biologic development as a combination therapy with other anti-cancer agents, including ASPEN-06, under phase 2 clinical study for treating Gastric/GEJ cancer.

Frequently asked questions

What is Alx Oncology Holdings Inc's market cap?

Alx Oncology Holdings Inc's market capitalization is USD 296.04M.

What does Alx Oncology Holdings Inc do?

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States.